Author: sHq_LoGiNz

On September 3, Cascale welcomed more than 50 brand & retailer members and stakeholders to an exclusive Q&A webinar, Higg FSLM: Meet the Experts. The session offered a unique opportunity for members to engage directly with the experts behind the Higg Facility Social & Labor Module (Higg FSLM), part of the Higg Index suite of tools. The Higg Index — owned and developed by Cascale, and exclusively available on Worldly — helps brands, retailers, and manufacturers understand and improve performance across environmental and social impact areas, and the Higg FSLM specifically focuses on measuring and improving social and labor conditions in global supply chains.

The webinar was hosted by Hamza Habib Hasan, senior membership engagement manager for brand & retailer membership at Cascale, and featured presentations from:

• Orine Dsouza, senior manager, Higg Facility Tools, Cascale
• Laura Jans, customer growth manager, SLCP
• Camille Stripoli, stakeholder engagement & partnerships manager, SLCP
• Leah Jaggars, senior manager, customer education, Worldly

Together, they explained how the Higg FSLM is powered by a tripartite collaboration:

• SLCP develops and maintains the Converged Assessment Framework (CAF), the foundation of the Higg FSLM, to collect and verify social and labor data with the goal of reducing audit fatigue.
• Cascale integrates the CAF into the Higg FSLM, providing the scoring methodology and benchmarking tools that drive continuous improvement.
• Worldly hosts the technology platform that makes it possible to complete the Higg FSLM and enables supply chain collaboration.

Experts shared how the Higg FSLM’s standardized scoring methodologies support facilities and brands to identify and prioritize risk more effectively. Dsouza also highlighted how tool developments are accelerated through the work of Cascale’s Member Expert Teams (METs) and Strategic Councils — governance bodies that bring together member perspectives to ensure industry alignment and practical usability of the tools.

This was followed by a deep dive into the SLCP CAF, which emphasized SLCP’s ongoing commitment to aligning the framework with human rights due diligence (HRDD) requirements. Members also heard updates on data availability, with CAF now accessible in 122 countries and regions, and were directed to key resources from all three organizations to support adoption and use.

The event concluded with a candid Q&A session, where members clarified the methodology, gained a deeper understanding of the scoring system, and shared feedback with the organizations leading this work.

This webinar reflects Cascale’s ongoing commitment to support members with opportunities to connect directly with experts, gain clarity on industry-leading tools like the Higg FSLM, and share feedback that helps shape future developments. By creating spaces for education and dialogue, Cascale strengthens member capacity to adopt solutions that reduce duplication, improve data quality, and accelerate progress on social and labor priorities.

Cascale members may access the session recording and summary on Cascale Connect here.

• Memorandum of Understanding aims to identify technologies within Baker Hughes’ and PETRONAS’ broad portfolio of solutions that are complementary and have potential to support Asia’s energy expansion and transition demands
• Companies to collaborate also to support growing installed base in the region through initiatives that strengthen local supply chain and services capabilities for gas projects, including training and talent development
• As a first step to enhance local services capabilities, Baker Hughes will expand existing gas technology services facility footprint to develop a full aeroderivative gas turbine module repair services facility inclusive of testing capabilities

KUALA LUMPUR, Malaysia, HOUSTON and LONDON, September 8, 2025 /3BL/ – Baker Hughes, an energy technology company, and Petroliam Nasional Berhad (PETRONAS), announced that they have entered a memorandum of understanding (MoU) on a strategic partnership to explore business initiatives that have the potential to support the delivery of Asia’s energy expansion and transition. 

The MoU serves as a foundation for collaboration initiatives between the two companies to enhance local supply chain capabilities and explore the feasibility of implementing a variety of technology solutions including:

• Enhanced LNG services footprint and cross-border talent training and development programs to strengthen local field operations capabilities
• Exploration & production, chemicals and mature assets solutions
• Digital solutions, including AI
• Sustainable energy solutions including carbon capture, utilization and storage (CCUS), as well as lubricants and biofuels for turbomachinery supply chain

In support of these initiatives, Baker Hughes announced plans to expand on its existing services footprint in Malaysia to develop a full aeroderivative gas turbine module repair services facility, inclusive of disassembly, assembling, grinding and testing capabilities. With an installed base of over 600 gas turbines and continued expected growth given the energy expansion, these augmented services capabilities will provide enhanced service to customers across the region with the aim to accelerate service turnaround time and enable continued best-in-class reliability and availability.

“It is critically important to grow alongside our customers in Asia-Pacific, including PETRONAS, as we work toward our shared goal of sustainable energy development to provide for a world that needs more reliable, secure and lower-carbon energy,” said Baker Hughes Chairman and CEO Lorenzo Simonelli. “We look forward to working alongside PETRONAS, as well as other local partners, to realize this additional localization effort to help ensure energy is available today and in the future.” 

PETRONAS Senior Vice President of Projects, Technology & Health, Safety, Security & Environment (PT&HSSE) Ir. Ts. Mohd Yusri Mohamed Yusof said, “Our extended strategic partnership with Baker Hughes is poised to drive excellence in project delivery, decarbonisation, supply chain resilience, and technology adoption. It signifies what’s possible when two industry leaders unite to foster innovation ecosystems and shape the future of energy. Furthermore, the setting up of an enhanced aeroderivative facility here is a positive development towards the region’s cleaner energy pursuit, underlining the strong partnerships needed to deliver Asia’s energy transition.”

Baker Hughes’ longstanding relationship with PETRONAS began in 1975, when the companies jointly pioneered LNG solutions for natural gas supply and collaborated on exploration and production projects. Currently Baker Hughes operates two turbomachinery services facilities in Malaysia: an aeroderivative gas turbine repairs facility in Port Klang, Selangor, which is operationalized through Aero Alliance, a joint venture between Baker Hughes and GE Vernova; and a heavy-duty gas turbine technology repairs, field service and digital services facility operated through its joint venture with Sapura Energy.  

Baker Hughes also operates two supply bases to support its in-country oilfield services operations, while a Kuala Lumpur based iCenter™ facility provides monitoring and diagnostics for Baker Hughes’ turbomachinery equipment across the region.  

Baker Hughes is currently undergoing assessments to identify the best location for placing its new expanded aeroderivative gas turbine services footprint in the country. 

About Baker Hughes
Baker Hughes (NASDAQ: BKR) is an energy technology company that provides solutions to energy and industrial customers worldwide. Built on a century of experience and conducting business in over 120 countries, our innovative technologies and services are taking energy forward – making it safer, cleaner and more efficient for people and the planet. Visit us at bakerhughes.com.

For more information, please contact:
Media Relations
Chiara Toniato
+39 3463823419
chiara.toniato@bakerhughes.com

Media Relations – Asia Pacific 
Adeline Teo
+65 8380 4045
Adeline.Teo@bakerhughes.com

• Credelio Quattro marked $100 million in net sales making it Elanco’s fastest pet health blockbuster in history and one of the industry’s fastest ever, especially with a single geographic approval
• Credelio Quattro joins Experior® as Elanco’s second of six recently launched blockbuster-potential products to reach the $100 million annual net sales milestone
• Zenrelia™ (ilunocitinib tablets) now in market in the European Union (EU) and Great Britain

GREENFIELD, Ind., September 8, 2025 /3BL/ – Elanco Animal Health Incorporated (NYSE: ELAN) has announced significant advancements with its two most recent pet health innovations — Credelio Quattro and Zenrelia — further demonstrating the company’s commitment to helping pet owners and veterinarians around the world go beyond today’s standard of treatment.

Credelio Quattro, Elanco’s latest parasite innovation brought to market, became Elanco’s fastest pet health blockbuster in history and one of the industry’s fastest ever, especially with a single geographic approval, reaching blockbuster status of $100 million in net sales in less than eight months. Credelio Quattro offers the broadestⁱ parasite protection available in an isoxazoline endectocide covering six types of parasites — fleas, ticks, heartworm disease, and three risky intestinal parasites — roundworms, hookworms, and tapeworms. 

“Credelio Quattro continues to break boundaries when it comes to offering veterinarians and pet owners parasite protection,” said Bobby Modi, Executive Vice President, U.S. Pet Health and Global Digital Transformation at Elanco. “We’re seeing incredibly strong demand for all-in-one products from pet owners and veterinarians alike. In fact, Credelio Quattro captured approximately 14% of the dollar share in broad-spectrum sales out of U.S. veterinary clinics in June. The introduction of Credelio Quattro has bolstered our broader Elanco portfolio in U.S. veterinary clinics, with Elanco now offering veterinarians a complete ecto, endo, and endecto portfolio with a variety of parasite coverage at a variety of price points to meet veterinarian and pet owner needs.”

Human and pet cases of tickborne disease, such as Lyme disease which is spread by the black-legged tick, are on the rise. According to the Companion Animal Parasite Council (CAPC), black-legged ticks are found across much of the eastern half of the United States, with aggressive populations in the North that appear to pose a higher risk of transmitting Lyme disease to humans and dogs; and these populations are also spreading South and West in the United States, as well as northward into new areas of Canada. Multiple studies have shown that areas of high risk for dogs are the same areas that humans are most likely to test positive for Lyme disease as well. CAPC recommends using products on pets that repel or quickly kill ticks before pathogens are transmitted. Credelio Quattro (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) also contains lotilaner that kills ticksⁱⁱ fasterⁱⁱⁱ than sarolaner in Simparica Trio^® and afoxolaner in NexGard^®, protecting dogs against pathogen-carrying ticks.

“When I talk to veterinarians and pet owners, I hear they want something that’s reliable, that’s going to be easy to give and that’s powerful against the different parasites: heartworms, ticks, and intestinal parasites including hookworms and tapeworms,” said Dr. Lindsay Starkey, veterinarian and tenured Associate Professor of Parasitology at Oklahoma State University’s College of Veterinary Medicine. “Credelio Quattro meets all of these expectations with its broad spectrum parasite control.”

Credelio Quattro joins Experior® as Elanco’s second of six recently launched blockbuster-potential products to reach the blockbuster milestone of $100 million annual net sales. Elanco continues to prepare to take Credelio Quattro global, with numerous submissions made in Australia, Canada, the EU, the UK, and Japan, setting up the company’s expected geographic expansion for the product starting in 2026.

Zenrelia Now in Market in EU and Great Britain

Zenrelia, an effective, convenient, and safe once-daily oral JAK inhibitor, continues its launch progress globally, gaining approval from the United Kingdom’s Veterinary Medicines Directorate in August. Additionally, launch progress continues across the EU and Great Britain with product supply now in market for veterinarians and pet owners. 

“Now we have a medication that is once a day right from the start. I think it will really help improve that owner, patient, pet bond, it will hopefully help reduce caregiver burden and will improve patient and carer quality of life as well,” said Dr. Victoria Robinson BVM&S, BSc, CertAVP (VD), DipECVD, MRCVS, RCVS and European Specialist in Veterinary Dermatology. “Knowing what I currently know about Zenrelia, I am keen to use it in the clinic and start prescribing it.”

This launch represents a pivotal milestone within the international canine dermatology market, offering a single daily dose for controlling pruritus (itching) associated with allergic dermatitis and atopic dermatitis in dogs over 12 months of age. Zenrelia is now available in the European Union, Great Britain, Brazil, Canada, Japan, and the United States. The Zenrelia EU label is consistent with other markets outside North America where the product has already been approved. 

“Zenrelia joins our exciting, growing international pet health portfolio, including AdTab, Credelio Plus, Galliprant (grapiprant tablets) and others,” said Ramiro Cabral, Executive Vice President, Elanco International. “We are very pleased with the results we are seeing in the global market, with more than half a million dogs treated with Zenrelia.” 

As part of the EU approval process, Elanco conducted a head-to-head non-inferiority study versus the marketplace incumbent, Apoquel. The randomized, double-blind study of 338 client-owned dogs with confirmed atopic dermatitis was conducted across 25 study sites in four countries. The study is published in a leading peer-reviewed, international journal, Veterinary Dermatology: https://doi.org/10.1111/vde.13319.     

ABOUT ELANCO​

Elanco Animal Health Incorporated (NYSE: ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders and society as a whole. With 70 years of animal health heritage, we are committed to breaking boundaries and going beyond to help our customers improve the health of animals in their care, while also making a meaningful impact on our local and global communities. At Elanco, we are driven by our vision of Food and Companionship Enriching Life and our purpose – all to Go Beyond for Animals, Customers, Society and Our People. Learn more at www.elanco.com.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

This press release contains forward-looking statements within the meaning of the federal securities laws, including, without limitation, statements concerning expected regulatory approvals and commercial expansion plans. Forward-looking statements are based on our current expectations and assumptions regarding our business, the economy and other future conditions. Because forward-looking statements relate to the future, by their nature, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. As a result, our actual results may differ materially from those contemplated by the forward-looking statements. Important risk factors that could cause actual results to differ materially from those in the forward-looking statements include regional, national or global political, economic, business, competitive, market and regulatory conditions, our ability to obtain regulatory approval of our products in different jurisdictions, the availability of adequate supply of products, and additional factors that could cause actual results to differ materially from forward-looking statements described in the company’s latest Form 10-K and Form 10-Qs filed with the Securities and Exchange Commission. We caution you against relying on any forward-looking statements, which should also be read in conjunction with the other cautionary statements that are included elsewhere in this press release. Any forward-looking statement made by us in this press release speaks only as of the date thereof. We undertake no obligation to publicly update or to revise any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.

Indications for Zenrelia 

Zenrelia is a prescription medication used to control itching and inflammation associated with skin allergies for dogs over 12 months of age.

IMPORTANT SAFETY INFORMATION

See package insert including the Boxed Warning. For full prescribing information speak with your veterinarian, call 1 888 545 5973 or visit www.elancolabels.com/us/zenrelia.

WARNING: VACCINE-INDUCED DISEASE AND INADEQUATE IMMUNE RESPONSE TO VACCINES. Based on results of the vaccine response study, dogs receiving Zenrelia are at risk of fatal vaccine-induced disease from modified live virus vaccines and inadequate immune response to any vaccine. Discontinue Zenrelia for at least 28 days to 3 months prior to vaccination and withhold Zenrelia for at least 28 days after vaccination. Dogs should be up to date on vaccinations prior to starting Zenrelia. Do not use in dogs less than 12 months old or dogs with a serious infection. Dogs should be monitored for the development of infections because Zenrelia may increase the chances of developing an infection. Neoplastic conditions (benign and malignant) were observed during clinical studies. The most common side effects were vomiting, diarrhea and tiredness. Zenrelia has not been tested in dogs used for breeding, pregnant, or lactating dogs and has not been evaluated in combination with glucocorticoids, cyclosporine, or other immune suppressive drugs.

Indications for Credelio Quattro

Credelio Quattro is indicated for the prevention of heartworm disease and the treatment and control of roundworm, hookworm, and tapeworm infections. Credelio Quattro kills adult fleas and is indicated for the treatment and prevention of flea infestations and the treatment and control of tick infestations for 1 month in dogs and puppies 8 weeks of age and older and weighing 3.3 pounds or greater.

Important Safety Information for Credelio Quattro

Lotilaner, an ingredient in Credelio Quattro, belongs to the isoxazoline class and has been associated with neurologic adverse reactions like tremors, ataxia, and seizures even in dogs without a history of seizures. Use with caution in dogs with a history of seizures or neurologic disorders. Dogs should be tested for existing heartworm infections before Credelio Quattro administration as it is not effective against adult D. immitis. The safe use in breeding, pregnant, or lactating dogs has not been evaluated. The most frequently reported adverse reactions in clinical trials were vomiting and diarrhea. For complete safety information, please see the Credelio Quattro product label or ask your veterinarian.

ⁱ Based on label comparison of the number of parasite types covered in an isoxazoline endectocide

ⁱⁱ Amblyomma americanum (lone star tick)

ⁱⁱⁱ Based on time to statistical significance vs control in a head-to-head study. The study compared Credelio™ (lotilaner)—not Credelio Quattro™, which contains lotilaner as well as moxidectin, praziquantel, and pyrantel—to the active ingredients in Simparica Trio™ (sarolaner, moxidectin, and pyrantel) and NexGard™ (afoxolaner). 

Media Contact

Colleen Parr Dekker
+1.317.989.7011
colleen.dekker@elancoah.com

Investor Contact

Tiffany Kanaga
+1.765.740.0314
tiffany.kanaga@elancoah.com

HONG KONG, September 8, 2025 /3BL/ – Federal Express Corporation, one of the world’s largest express transportation companies, has announced the expansion of its electric vehicle (EV) fleet in Hong Kong with the addition of six new panel vans for parcel pickup and delivery operations. Deploying additional EVs advances FedEx’s efforts towards reducing its operational carbon footprint in Hong Kong and achieving carbon-neutral operations globally by 2040.

Equipped with a load capacity of up to 913 kilograms and an estimated range of 264 kilometers per charge, the new Mercedes-Benz eVito panel vans have been deployed across key high-traffic districts throughout Hong Kong. Featuring an advanced technology system, ample storage space and ergonomic seating, the vans are designed for comfort and functionality during deliveries. EVs generally have lower total cost of ownership, are more energy-efficient, and produce fewer air pollutants and carbon emissions compared to traditional internal combustion engine vehicles[1]. These advantages enhance operational efficiency and reduce environmental impacts.

As more consumers turn to online shopping and prioritize sustainability in their purchasing decisions, FedEx’s integration of additional EVs in Hong Kong operations addresses the evolving preferences of local customers. Recent survey findings reveal that a majority of Hong Kong customers (73%), particularly Gen Z and Millennials, consider sustainability elements when choosing brands, products and services. They are also keen on learning more about these brands’ future sustainability plans[2]. In addition, nearly half of the customers (49%) have reduced or ceased purchasing from brands that do not prioritize sustainability[3].

“Adding new EVs to our local delivery fleet underscores our commitment to enhancing Hong Kong’s contribution to FedEx global sustainability efforts,” said Anthony Leung, managing director, FedEx Hong Kong and Macau. “With growing demand for reliable and sustainable options among Hong Kong customers, expanding our EV fleet is crucial for supporting sustainable development. As we work towards our goal of carbon-neutral global operations by 2040, FedEx is dedicated to transforming the logistics industry with innovative and sustainable solutions that meet evolving market needs.”

FedEx plans to continue adding electric vehicles to its Hong Kong fleet in the coming years, in pursuit of its goal to have a 100% electric pickup and delivery fleet by 2040. Beyond deploying EVs, FedEx continues to develop sustainability initiatives that advance the goals of the company, its customers and the communities the company serves. The company previously launched FedEx® Sustainability Insights in Hong Kong, a cloud-based carbon emissions reporting tool that provides customers with historical emissions data for their shipments within the FedEx network. This information empowers customers to make more informed decisions about their shipping strategies and mitigate their environmental impact. Additionally, FedEx has collaborated with local social enterprises to repurpose unused uniforms and shipping materials, paving the way for circular supply chains with less waste.

Click here to learn about FedEx Cares, our global community engagement program.

[1] About electric vehicles
[2] Sustainable Consumer Choice Survey Report 2024
[3] Sustainable Consumer Choice Survey Report 2024

The intersection of climate-driven weather events, geopolitical instability, and evolving trade policies turns supply chain disruption into a persistent challenge. As organizations navigate these turbulent conditions, Environmental, Health, and Safety (EHS) teams are stepping into a more strategic role, ensuring compliance, continuity and resilience.

Today, EHS professionals are involved in enterprise risk management, business continuity planning, and resource stewardship. In this blog, we explore how EHS leaders can strengthen resilience by preparing for disruption scenarios, engaging local expertise, maintaining compliance, and stewarding energy and water resources.

Understanding the New Normal of Disruption

Disruption has become the new baseline. These disruptions take the form of extreme weather events that damage infrastructure, raw material shortages, labor instability, and logistical breakdowns. As a result, global supply chains are more fragile than ever. 

Each of these disruptions has cascading EHS implications:

• Facility shutdowns due to flooding, fires, or energy outages.
• Worker relocations that introduce new health and safety risks.
• Compliance challenges as operations move across regions with different regulations.

Among the most pressing concerns are access to water and energy, both of which are increasingly unpredictable. EHS strategies must now factor into these core resource risks as part of business continuity planning.

Proactive EHS Planning for Supply Chain Disruption Scenarios

Resilient organizations plan and prepare for disruptions. They can’t afford to wait for an emergency to strike and then haphazardly respond while it grows into a catastrophe.

Leading EHS teams are embedding disruption scenarios into their risk assessments, asking:

• What happens if a facility loses water access?
• How do we protect workers if production shifts to a new geography?
• Can we reduce dependency on vulnerable suppliers or resources?

Meaningful scenario planning should include:

• Energy availability: Anticipating power disruptions or cost volatility.
• Water access: Managing supply limitations or usage restrictions.
• Circular resource strategies: Using recycled materials, closed-loop systems, or alternative inputs.

By integrating EHS considerations into supply chain due diligence, companies can make smarter sourcing decisions and reduce exposure to future operational shocks.

The Value of Localized Expertise and Flexibility

Environmental regulations and resource availability differ drastically across regions. For example, a manufacturing site in California may face strict water-use rules, while a counterpart in Vietnam may struggle with waste infrastructure or air quality controls.

To stay agile and compliant, best practices include:

• Getting the benefits of a local perspective from EHS consultants who understand environmental constraints and enforcement practices.
• Leveraging global EHS networks to ensure consistent standards while adapting to local realities.

Workforce Safety and Mobility Under Strain

With a truly global workforce, companies can struggle with bridging occupational safety across borders. One primary issue is that the health and safety risks can vary based on the geography and site conditions, so global protocols are impractical and even dangerous.

Another challenge is the normalization of remote work in field team oversight. Remote work adds complexity to field team oversight and emergency response. The best solution is to partner with local EHS consultants who can ensure workplace safety by creating practical risk assessments.

Local EHS consultants also are crucial partners for training. Language and cultural differences can reduce the effectiveness of training and communication, so these partners are key to overcoming these barriers.

Regulatory Watch: Staying Compliant During Change

Disruption is often a catalyst for regulatory change. For example:

• New emissions caps during climate events
• Revised permitting requirements for relocated production
• Emergency health and safety mandates following political unrest

Compliance remains non-negotiable, even in crisis. EHS teams need local monitoring tools like regulatory registers and proactive planning to stay ahead of change.

The latest episode of Rethinking EHS (Season 2, Ep. 1) explores how companies are managing regulatory shifts across regions like APAC, Europe, and the Americas, highlighting tools and strategies for staying ahead.

Building Resilience Through EHS

Supply chain disruption is not going away. For EHS leaders, this means planning for continuous change, balancing global standards with local execution. EHS plays a vital role in ensuring operational resilience by maintaining compliance, supporting workforce safety, and reducing energy and water risk.

For insights you can apply to your own EHS strategy, listen to Rethinking EHS: Leading EHS Through Uncertainty. In this episode, Inogen Alliance members share how companies are responding to energy transition, shifting supply routes, regulatory divergence, and climate-driven resource stress. 

Access the Podcast Episode

Inogen Alliance is a global network made up of over 70 of independent local businesses and over 6,000 consultants around the world who can help make your project a success. Our Associates collaborate closely to serve multinational corporations, government agencies, and nonprofit organizations, and we share knowledge and industry experience to provide the highest quality service to our clients. If you want to learn more about how you can work with Inogen Alliance, you can explore our Associates or Contact Us. Watch for more News & Blog updates, listen to our podcast and follow us on LinkedIn.